You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 18, 2024

Investigational Drug Information for BAY1817080


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for BAY1817080?

BAY1817080 is an investigational drug.

There have been 14 clinical trials for BAY1817080. The most recent clinical trial was a Phase 2 trial, which was initiated on October 2nd 2020.

The most common disease conditions in clinical trials are Urinary Bladder, Overactive, Endometriosis, and Neuralgia. The leading clinical trial sponsors are Bayer and [disabled in preview].

There are four US patents protecting this investigational drug and seventy-one international patents.

Recent Clinical Trials for BAY1817080
TitleSponsorPhase
A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese MenBayerPhase 1
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually BayerPhase 2
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic PainBayerPhase 2

See all BAY1817080 clinical trials

Clinical Trial Summary for BAY1817080

Top disease conditions for BAY1817080
Top clinical trial sponsors for BAY1817080

See all BAY1817080 clinical trials

US Patents for BAY1817080

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
BAY1817080 ⤷  Try a Trial 1,3-thiazol-2-yl substituted benzamides BEYER AKTIENGESELLSCHAFT (Leverkusen, DE) ⤷  Try a Trial
BAY1817080 ⤷  Try a Trial 1,3-thiazol-2-yl substituted benzamides Bayer Aktiengesellschaft (Leverkusen, DE) ⤷  Try a Trial
BAY1817080 ⤷  Try a Trial 1,3-thiazol-2-yl substituted benzamides Bayer Aktiengesellschaft (Leverkusen, DE) ⤷  Try a Trial
BAY1817080 ⤷  Try a Trial 1,3-thiazol-2-yl substituted benzamides Bayer Aktiengesellschaft (Leverkusen, DE) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for BAY1817080

Drugname Country Document Number Estimated Expiration Related US Patent
BAY1817080 Argentina AR102948 2034-12-09 ⤷  Try a Trial
BAY1817080 Argentina AR119761 2034-12-09 ⤷  Try a Trial
BAY1817080 Australia AU2015359626 2034-12-09 ⤷  Try a Trial
BAY1817080 Brazil BR112017012327 2034-12-09 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.